Thesan Pharmaceuticals Secures $49,000,000 Series B Financing

  • Feed Type
  • Date
    2/25/2014
  • Company Name
    Thesan Pharmaceuticals
  • Mailing Address
    392 Camino de Estrella San Clemente, CA 92672
  • Company Description
    Thesan Pharmaceuticals, Inc. is a preclinical biopharmaceutical company dedicated to the development of novel therapeutics for disorders of the skin. Thesan is focused on the discovery and development of New Chemical Entities that have the potential to provide significantly improved treatment options to patients.
  • Website
    http://www.thesanpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $49,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    We are very pleased with the deep financial backing provided by four top tier venture funds, which puts us in an unparalleled position as a biopharma to develop new drugs in this area.
  • M&A Terms
  • Venture Investor
    Novo Ventures
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    Lundbeckfond Ventures
  • Venture Investor
    Novartis Venture Fund

Trending on Xconomy